<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01881685</url>
  </required_header>
  <id_info>
    <org_study_id>RP#12018</org_study_id>
    <nct_id>NCT01881685</nct_id>
  </id_info>
  <brief_title>Fetal Intrapartum Heart Rate FHR/ECG Study</brief_title>
  <official_title>Fetal Intrapartum Heart Rate FHR/ECG Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mindchild Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mindchild Medical Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate the association between certain markers in the&#xD;
      blood of neonatal brain injury and specific Fetal Heart Rate monitoring findings using the&#xD;
      device under study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to:&#xD;
&#xD;
        1. evaluate the association between serologic markers of neonatal brain injury and the&#xD;
           specific FHR monitoring findings using the investigational device;&#xD;
&#xD;
        2. investigate the relationship between selective serotonin reuptake inhibitor (SSRI)&#xD;
           antidepressants and the QT interval of the fetal heart. Specifically, examine the&#xD;
           potential association between maternal SSRI use and the fetal QT interval,and;&#xD;
&#xD;
        3. develop the capacity to measure uterine contractions during labor using non-invasive&#xD;
           electrodes that measure the electrical signal from the uterine muscle.&#xD;
&#xD;
      For this study, the investigational device will not be used to diagnose or treat as it will&#xD;
      be used in concert with the current standard of care monitors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Quantitative FHR patterns predictive of adverse neonatal outcome</measure>
    <time_frame>During Labor</time_frame>
    <description>1)quantitative analysis of fetal heart-rate (FHR) data recorded during labor using advanced mathematical techniques, including pattern-recognition analysis using EKG stickers applied to the maternal abdomen.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Uterine contraction measurement</measure>
    <time_frame>During Labor</time_frame>
    <description>Uterine contraction monitoring using skin surface electrodes</description>
  </secondary_outcome>
  <enrollment type="Actual">400</enrollment>
  <condition>Abnormality in Fetal Heart Rate or Rhythm</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      1) umbilical cord arterial and venous blood; 2)placenta for pathological evaluation.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women in labor who are having their fetus' heart rate monitored continuously&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women in their third trimester and Women in labor (the progressive effacement&#xD;
             and dilatation of the cervix) who are having their fetus' heart rate monitored&#xD;
             continuously will form the eligible population for recruitment into our study&#xD;
&#xD;
          -  18 years old or older&#xD;
&#xD;
          -  Women with the diagnosis of fetal intrauterine growth restriction may be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Speakers of languages other than English&#xD;
&#xD;
          -  Gestational age less than 24 weeks 0 days&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Drake, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Summa Center for Women's Health Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summa Center for Women's Health Research</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>June 11, 2013</study_first_submitted>
  <study_first_submitted_qc>June 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2013</study_first_posted>
  <last_update_submitted>September 17, 2019</last_update_submitted>
  <last_update_submitted_qc>September 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

